| Not Yet Recruiting | Precise Cooler for Donor Heart Transport NCT07354763 | Cedars-Sinai Medical Center | N/A |
| Recruiting | Multimodal Analysis of Endomyocardial Biopsies NCT07359690 | University Hospital, Essen | — |
| Recruiting | Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Gener NCT07291258 | University Medical Center Groningen | — |
| Recruiting | Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery NCT07096973 | Hochgebirgsklinik Davos | — |
| Recruiting | METABolic Deterioration in HTX Determines Outcomes NCT07372820 | Heinrich-Heine University, Duesseldorf | — |
| Recruiting | ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Trans NCT06982404 | Medical University of Vienna | — |
| Recruiting | A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart NCT07531784 | Karolinska Institutet | — |
| Not Yet Recruiting | Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Manageme NCT06774768 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease NCT06325280 | University of Alberta | — |
| Not Yet Recruiting | CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation NCT06774365 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTI NCT06341543 | University Hospital, Grenoble | N/A |
| Recruiting | Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure NCT06556485 | Heart and Diabetes Center North-Rhine Westfalia | N/A |
| Not Yet Recruiting | Genomics in Heart Transplants NCT06012162 | Heinrich-Heine University, Duesseldorf | — |
| Recruiting | Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation NCT05909150 | Fernando Bacal | Phase 2 |
| Active Not Recruiting | First Clinical Evaluation of Heart Transplantation With Grafts Preserved Using an Ex-vivo Extended Perfusion S NCT06035991 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Donor Circadian Rhythm and Its Correlation With Prognosis After Heart Transplantation NCT07301788 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Recruiting | Precision Medicine in the Management of Heart Transplant Recipients NCT06774794 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Electronic Register on Advanced Heart Failure and Transplantation di Cuore NCT06773611 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Study of Organ Perfusion in Heart Transplantation in Children NCT06032195 | Dr. F. Köhler Chemie GmbH | Phase 2 |
| Recruiting | Pericoronary Adipocyte Size Gradient NCT07360925 | Institute for Clinical and Experimental Medicine | — |
| Recruiting | Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transpla NCT06813443 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Brachial Right Ventricle - Endomyocardial Biopsy NCT05289180 | NYU Langone Health | — |
| Recruiting | The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients NCT05729009 | National Institute of Cardiology, Laranjeiras, Brazil | — |
| Recruiting | Haemoadsorption During Heart Transplantation NCT05270902 | Medical University of Vienna | N/A |
| Completed | Remote Ischemic Preconditioning and Acute Kidney Injury in HTX NCT05364333 | Heinrich-Heine University, Duesseldorf | N/A |
| Recruiting | IMPact of Donor Heart Function on Recipient Outcomes - a prospectiVE Study to Increase the Utilization of Dono NCT04393181 | Vastra Gotaland Region | — |
| Completed | Covid-19 Vaccine Response in Heart Transplant Recipients NCT05268679 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | Heart Transplantation Utilizing NRP DCD NCT05243914 | University of Arizona | — |
| Completed | Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft NCT06740578 | Paris Translational Research Center for Organ Transplantation | — |
| Recruiting | Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging NCT05081115 | Fatebenefratelli Hospital | — |
| Unknown | Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure NCT05008692 | University Health Network, Toronto | — |
| Active Not Recruiting | Non-ischemic Preservation of the Donor Heart in Heart Transplantation NCT03991923 | XVIVO Perfusion | N/A |
| Completed | Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantatio NCT04488094 | Asan Medical Center | Phase 2 |
| Recruiting | Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Ch NCT04924491 | Rafael Correa-Rocha | Phase 1 / Phase 2 |
| Recruiting | Belatacept in De Novo Heart Transplantation NCT04477629 | NYU Langone Health | Phase 2 |
| Completed | Sevice-learning in Physiotherapy and Heart Transplantation and Acute Coronary Syndrome NCT04261998 | University of Valencia | N/A |
| Completed | Cardiac Rehabilitation for Inpatient Heart Transplant (HRN4HTx) NCT06552390 | Instituto Politécnico de Bragança | N/A |
| Enrolling By Invitation | The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients NCT03292861 | Cedars-Sinai Medical Center | Phase 2 |
| Completed | Periodontal Status and Dental Behavior of Heart Trasplant Recipients and Healthy Controls NCT03809676 | Baskent University | — |
| Completed | Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation NCT03026634 | Heart and Diabetes Center North-Rhine Westfalia | — |
| Unknown | Satisfaction Degree in a Nurse Educational Program to Heart Transplant Patient NCT02938676 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Observational Study of the Clinical Use of the OCS™ Heart NCT03687723 | Hannover Medical School | — |
| Unknown | Urinary Proteomics in Predicting Heart Transplantation Outcomes NCT03152422 | KU Leuven | — |
| Completed | Cost-utility Analysis of the AlloMap® Test NCT02602691 | Hospices Civils de Lyon | N/A |
| Completed | SCHEDULE Follow Up Visit 5-7 yr NCT02864706 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Imminently Effect of Interval Training With High Intensity (HIT) After Heart Transplantation NCT02602834 | Oslo University Hospital | N/A |
| Completed | Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation NCT02376387 | Stanford University | — |
| Completed | Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2 NCT02261870 | Central Hospital, Nancy, France | N/A |
| Terminated | Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection NCT02300870 | Brigham and Women's Hospital | — |
| Completed | Pediatric Heart Transplantation: Transitioning to Adult Care NCT02090257 | Ann & Robert H Lurie Children's Hospital of Chicago | N/A |
| Terminated | Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy NCT01927614 | Nova Scotia Health Authority | — |
| Terminated | Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation NCT01769443 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Unknown | Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement NCT01705015 | National Taiwan University Hospital | N/A |
| Unknown | Genetic Predictors of Renal Dysfunction Following Heart Transplantation NCT01686191 | University of Colorado, Denver | — |
| Terminated | Multi-Drug Desensitization Protocol for Heart Transplant Candidates NCT01556347 | Providence Health & Services | Phase 2 |
| Completed | A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medicat NCT01614665 | Astellas Pharma Europe Ltd. | Phase 2 |
| Unknown | Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation NCT01608477 | University of Basel | — |
| Unknown | Pharmacology of Immunosuppressants Following Heart Transplantation NCT01423552 | Nigel E. Drury | — |
| Completed | Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation NCT01655563 | The Hospital for Sick Children | Phase 2 |
| Completed | Measurements of Myocardial Relaxation Time by MRI During Respiration NCT03234205 | Central Hospital, Nancy, France | N/A |
| Completed | Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or P NCT01332201 | Astellas Pharma Inc | Phase 2 |
| Terminated | A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipient NCT01371344 | Astellas Pharma Europe Ltd. | Phase 4 |
| Completed | A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Org NCT01371331 | Astellas Pharma Europe Ltd. | Phase 4 |
| Completed | Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Pr NCT01294020 | Astellas Pharma Europe Ltd. | Phase 2 |
| Completed | Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE) NCT03105726 | Joe Elie Salem | — |
| Completed | Effect of Exercise After Heart Transplantation NCT01091194 | Oslo University Hospital | Phase 2 |
| Completed | Effect of Physical Training on Oxygen Uptake and Endothelial Function in Heart Transplant Recipients NCT01028599 | Rigshospitalet, Denmark | N/A |
| Unknown | Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy NCT00966836 | University of Bologna | Phase 3 |
| Completed | A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in NCT00862979 | Novartis Pharmaceuticals | Phase 4 |
| Withdrawn | Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients NCT00780377 | Vanderbilt University | N/A |
| Withdrawn | Brachial Artery t-PA Release in Heart Transplant Recipients NCT00780637 | Vanderbilt University | N/A |
| Completed | Exploration of Fatigue, Uncertainty, Depression and Quality of Life in Heart Transplantation Recipients NCT01182571 | National Taiwan University Hospital | — |
| Terminated | Quality of Life in Pediatric Transplant Patients NCT00678002 | Medical College of Wisconsin | — |
| Withdrawn | Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant R NCT00709293 | University of California, Los Angeles | N/A |
| Withdrawn | Comparison of Coronary CT With IVUS in Heart Transplant Population NCT00589524 | Mayo Clinic | N/A |
| Completed | Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival NCT00531921 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Unknown | Safe Renal Function In Long Term Heart Transplanted Patients NCT00505102 | A.O. Ospedale Papa Giovanni XXIII | Phase 4 |
| Completed | Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Pa NCT00723281 | University of California, San Francisco | — |
| Terminated | Shift to Everolimus (RAD) Kidney Sparing Study NCT00420537 | University of Bologna | Phase 4 |
| Completed | A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients. NCT02091414 | Hoffmann-La Roche | Phase 3 |
| Completed | Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients NCT00574197 | Cedars-Sinai Medical Center | Phase 4 |
| Completed | Metabolic Pattern of Cyclosporine A and Acute Renal Failure NCT00264355 | University of Oslo School of Pharmacy | Phase 4 |
| Completed | Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation NCT00297830 | Columbia University | Phase 2 / Phase 3 |
| Withdrawn | Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study NCT00572286 | Cedars-Sinai Medical Center | — |
| Terminated | Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in NCT00121784 | Hoffmann-La Roche | Phase 4 |
| Completed | Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy NCT00469911 | Washington University School of Medicine | N/A |
| Completed | Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Follo NCT00139009 | University of Oslo School of Pharmacy | Phase 4 |
| Completed | Quality of Life in Pediatric Transplant Recipients NCT00209196 | Emory University | — |
| Completed | Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients NCT00150046 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients NCT00169936 | Mayo Clinic | Phase 3 |
| Completed | Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplan NCT00359658 | Hannover Medical School | N/A |
| Completed | Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation NCT00359814 | Hannover Medical School | N/A |
| Unknown | Fluvastatin After Heart Transplantation NCT00421005 | University of Bologna | Phase 4 |
| Completed | A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients NCT00098007 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Mainten NCT00170859 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic NCT00157014 | Astellas Pharma Inc | Phase 3 |
| Terminated | Thymic Tolerance in Pediatric Heart Transplantation NCT00151164 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Preventi NCT02554955 | Hoffmann-La Roche | Phase 4 |
| Completed | L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function NCT00213915 | University Hospital, Strasbourg, France | Phase 4 |
| Completed | Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation NCT04117152 | Paris Translational Research Center for Organ Transplantation | — |
| Completed | Registry of Patients Referred for Heart Transplantation NCT00690157 | National Institute of Cardiology, Warsaw, Poland | — |
| Completed | Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Fun NCT00123331 | Heidelberg University | Phase 4 |
| Completed | Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion NCT00497757 | Suzanne T. Ildstad | Phase 1 / Phase 2 |
| Completed | Study of Heart Transplant Rejection NCT00042614 | National Institutes of Health Clinical Center (CC) | — |
| Unknown | The Association of Endothelial Dysfunction and Cardiac Allograft Vasculopathy NCT00173914 | National Taiwan University Hospital | — |
| Completed | Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long NCT02118896 | Astellas Pharma Europe Ltd. | Phase 3 |
| Completed | Nitrate and Hypertension in Heart Transplanted Patients NCT00449059 | University of Zurich | Phase 4 |
| Unknown | Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation NCT00752336 | Hannover Medical School | N/A |
| Completed | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MM NCT00574743 | Novartis Pharmaceuticals | Phase 4 |
| Completed | A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Cortico NCT00048165 | Hoffmann-La Roche | Phase 4 |
| Completed | Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation NCT00521573 | University of Zurich | Phase 1 |